Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

Corrigendum to ‘Editor’s Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections’ [European Journal of Vascular & Endovascular Surgery 59/3 (2020) 339-384]
Published in: European Journal of Vascular and Endovascular Surgery
The authors regret there were mistakes in Table 12 concerning adjusted risk estimation for surgical site infections of the lower limbs. The authors would like to thank Dr Tresson and colleagues for their careful reading and to apologise for any inconvenience.
Nabil Chakfé, Holger Diener, Anne Lejay, Ojan Assadian, Xavier Berard, Jocelyne Caillon, Inge Fourneau, Andor W J M Glaudemans, Igor Koncar, Jes Lindholt, Germano Melissano, Ben R Saleem, Eric Senneville, Riemer H J A Slart, Zoltan Szeberin, Maarit Venermo, Frank Vermassen, Thomas R Wyss, Esvs Guidelines Committee, Gert J de BorstFrederico B Gonçalves, Stavros K Kakkos, Philippe Kolh, Riikka Tulamo, Melina V de Ceniga, Document Reviewers, Regula S von Allmen, Jos C van den Berg, E Sebastian Debus, Mark J W Koelemay, Jose P Linares-Palomino, Gregory L Moneta, Jean-Baptiste Ricco, Anders Wanhainen
A systematic review and meta-analysis of F-18-fluoro-D-deoxyglucose positron emission tomography interpretation methods in vascular graft and endograft infection
Published in: Journal of Vascular Surgery
OBJECTIVE: Vascular graft and endograft infection (VGEI) has high morbidity and mortality rates. Diagnosis is complicated since symptoms vary and can be non-specific. A recent meta-analysis identified the use of 18F-fluoro-D-deoxyglucose positron emission tomography-computed tomography (18F-FDG PET(/CT)) as the most valuable tool for diagnosing VGEI and favorable to computed tomography as the current standard. However, the availability and varied use of several interpretation methods, without consensus on which interpretation method is best, complicates clinical use. The aim of this study was to evaluate the diagnostic performance of different...
Eline I Reinders Folmer, Gerdine C I von Meijenfeldt, Renske S Te Riet Ook Genaamd Scholten, Maarten J van der Laan, Andor W J M Glaudemans, Riemer H J A Slart, Clark J Zeebregts, Ben R Saleem
Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis
Published in: Rheumatology
Objectives. To compare colour duplex ultrasonography (CDU) findings with axillary F-18-fluorodeoxyglucose (FDG) PET/CT findings and to compare the diagnostic performance of temporal and axillary artery CDU with temporal artery CDU alone. Methods. Patients suspected of GCA were retrospectively included. Presence of a halo or occlusion was considered a positive CDU finding. FDG-PET/CT-assessed axillary artery involvement was defined as axillary artery FDG uptake higher than liver uptake. The reference was the clinical diagnosis after 6 months, which was based on symptomatology and additional diagnostic tests, with the exception of...
Diagnostic errors in clinical FDG-PET/CT
Published in: European Journal of Radiology
Purpose: To determine the frequency, types, and determinants of diagnostic errors in clinical FDG-PET/CT, based on addenda to the original report. Materials and Methods: This retrospective study included 4,099 consecutive clinical FDG-PET/CT scans with corresponding reports that were made at a tertiary care center in an 18-month period. FDG-PET/CT reports were scrutinized for the presence of an addendum enclosing a diagnostic error. Results: 90 of 4,099 FDG-PET/CT reports (2.2%) contained an addendum enclosing a diagnostic error. The distribution of perceptual and cognitive errors among these 90 diagnostic errors...
Evaluation of FES (16 alpha-[18F]-fluoro-17 beta-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer
R. Iqbal, C. Mo, M. C. F. Cysouw, A. W. J. M. Glaudemans, G. A. P. Hospers, C. P. Schroder, C. C. M. Venema, C. W. Menke-van der Houven van Oordt